June 21, 2012

The Food and Drug Administration has approved a branded acne drug made by Ranbaxy Labs, the drug maker said. Ranbaxy announced the FDA approval of Absorica (isotretinoin), a drug for treating severe recalcitrant nodular acne.

June 21, 2012

Faced with the possibility of a critical cutoff in funding for the Food and Drug Administration, Congress moved in late May to reauthorize the Prescription Drug User Fee Act that provides the bulk of the agency’s resources for new-drug review and approval. 


June 21, 2012

Specialty and biologically engineered medicines have been a boon to millions of Americans with life-threatening and life-altering conditions. But their lofty prices are squeezing patients and payers and spawning a growing legislative backlash that threatens insurers and employer-based health plans.

June 21, 2012

In 2008, an investigation by the Associated Press revealed that drinking water supplies in major cities and metropolitan regions across the country are riddled with pharmaceutical compounds.

June 20, 2012

Hamacher Resource Group on Tuesday announced it will present “Marketing Diabetes in the Retail Setting” June 21 at the Marketing Diabetes Prevention and Awareness Conference in Atlanta.

June 20, 2012

Pharmacy customers who use the Mscripts application to order, refill and manage their prescriptions now can do so in English or Spanish, the company announced Wednesday.

June 19, 2012

AstraZeneca and Rigel Pharmaceuticals have entered an exclusive worldwide license agreement for the global development and commercialization of an investigational treatment for moderate to severe chronic asthma.

June 19, 2012

The Food and Drug Administration has declined to approve a drug designed to treat a rare, progressive and fatal neurodegenerative disease.

June 19, 2012

Maxim Health Systems now is a certified distributor of the Citi Flu Care card, the healthcare group announced Tuesday.

June 19, 2012

Pfizer announced the results of its late-stage clinical trial of Xalkori (crizotinib).

June 19, 2012

A drug maker and a teaching and research affiliate of Harvard Medical School announced a new collaboration to promote the development of new medicines for the treatment of diabetes and related disorders.

June 19, 2012

A Takeda drug designed to treat hypertension was statistically superior to a competing drug in reducing systolic blood pressure among patients in a late-stage clinical trial.

June 18, 2012

Merck announced that the U.S. District Court for the District of New Jersey ruled against the company in a patent infringement suit against Canada-based drug maker Apotex.

June 18, 2012

A nonprofit global health and disaster relief organization has recognized a drug maker for its commitment to aiding disaster survivors and increasing access to health care around the world.

June 18, 2012

A healthcare company and a drug maker have entered a one-year research partnership to explore diabetes treatment and care.

June 18, 2012

Americans still are forgoing or delaying health care on account of the economy, according to the Kaiser Family Foundation, which recently released its May Health Tracking Poll.

June 15, 2012

GlaxoSmithKline has received regulatory approval from the Food and Drug Administration for a vaccine designed to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type B.

June 15, 2012

Valeant Pharmaceuticals International has agreed to acquire a specialty oral health company that develops and commercializes products that improve and maintain oral health.

June 14, 2012

Cellceutix on Wednesday reported that the Food and Drug Administration granted a section 505(b) designation for its Prurisol treatment for psoriasis, which would allow the company to forgo early-stage trials and advance Prurisol into latter-stage clinical trials.

June 14, 2012

Kadmon Pharmaceuticals earlier this month announced that it has launched a new 600 mg/day dose pack of Ribasphere RibaPak (ribavirin, USP), Kadmon's proprietary ribavirin regimen available in a daily, two-pill compliance package for enhanced therapy adherence.

June 14, 2012

Novo Nordisk and the Juvenile Diabetes Research Foundation on Wednesday announced the creation of a joint research and development team to discover and develop novel immunotherapies to prevent, treat and help cure Type 1 diabetes.

June 14, 2012

Stiefel, a GlaxoSmithKline company, on Monday acquired the eczema remedy Toctino (alitretinoin) from Basilea Pharmaceutica.

June 14, 2012

A new Walgreens study released Thursday found that a pharmacist-led training and counseling program for patients receiving an injectable diabetes medication improved medication adherence by 24%.

June 13, 2012

Bayer on Tuesday announced that on July 1, Philip Blake will become senior Bayer representative USA, following a common company practice of assigning this oversight role to a senior executive already holding a significant business role or roles within the region.